SINOGENE

SINOGENE creates an animal gene editing and somatic cell cloning technology platform.

Number of Funding Rounds

Total Funding Amount

3

¥80M

SINOGENE has raised a total of ¥80M in funding over 2 rounds. Their latest funding was raised on Jun 23, 2020 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 23, 2020	Series B	¥20M	2	Shunqi Touzi	—	Detail
Sep 1, 2018	Series Unknown	¥50M	1	—	—	Detail
Mar 21, 2018	Series A	¥10M	1	—	—	Detail

Number of Lead Investors

Number of Investors

1

4

SINOGENE is funded by 4 investors. Shunqi Touzi and Xinuo Hengtong are the most recent investors.

Investor Name	Lead Investor	Funding Round
Shunqi Touzi	Yes	Series B
Xinuo Hengtong	—	Series B
Jianchuang Zhongmin Chuangtou	—	Series Unknown
Lotus Lake Ventures	—	Series A